Dr. Timothy J. Miller is CEO, President and Co-Founder of Forge Biologics, Inc., a VC-backed gene therapy development engine focused on accelerating access to potentially life-saving (AAV) gene therapies. In this podcast, we talk with Dr. Miller about building Ohio's biotech hub and Forge's work in manufacturing gene therapies for life.
Dr. Miller was previously founding CEO & President of Abeona Therapeutics, a rare disease NASDAQ gene and cell therapy company. He's a proven biotech leader with experience in driving gene therapy pipeline development, regulatory strategy, investor relations, M&A activities, in-licensing, GMP manufacturing, clinical development and leading stakeholder and shareholder engagement.
Dr. Miller has over 20+ years of business development, scientific research, product development and clinical operations expertise, with a focus on transitioning novel gene and cell therapies through pre-clinical and human clinical trials.
He earned his Ph.D. in Pharmacology from Case Western Reserve University and a Bachelor of Science (B.S.) and Master of Science (M.S.) from John Carroll University. Dr. Miller is an avid patient-centric drug developer and entrepreneur.
For more information on Forge Biologics, please visit: www.forgebiologics.com
To learn about career opportunities with Forge, please visit: www.forgebiologics.com/careers/
And in 2021, Forge Biologics launched its Forge Ahead campaign to deliberately expand its impact by committing to raise awareness and support for people and families living with rare diseases. Learn more about this work (which includes pictures and video of the team climbing Mt. Adams!): https://insights.forgebiologics.com/forge-ahead-launches-with-support-for-be-the-match-and-hope-on-a-summit
Dr. Timothy J. Miller is CEO, President and Co-Founder of Forge Biologics, Inc., a VC-backed gene therapy development engine focused on accelerating access to potentially life-saving (AAV) gene therapies. In this podcast, we talk with Dr. Miller about building Ohio's biotech hub and Forge's work in manufacturing gene therapies for life.
Dr. Miller was previously founding CEO & President of Abeona Therapeutics, a rare disease NASDAQ gene and cell therapy company. He's a proven biotech leader with experience in driving gene therapy pipeline development, regulatory strategy, investor relations, M&A activities, in-licensing, GMP manufacturing, clinical development and leading stakeholder and shareholder engagement.
Dr. Miller has over 20+ years of business development, scientific research, product development and clinical operations expertise, with a focus on transitioning novel gene and cell therapies through pre-clinical and human clinical trials.
He earned his Ph.D. in Pharmacology from Case Western Reserve University and a Bachelor of Science (B.S.) and Master of Science (M.S.) from John Carroll University. Dr. Miller is an avid patient-centric drug developer and entrepreneur.
For more information on Forge Biologics, please visit: www.forgebiologics.com
To learn about career opportunities with Forge, please visit: www.forgebiologics.com/careers/
And in 2021, Forge Biologics launched its Forge Ahead campaign to deliberately expand its impact by committing to raise awareness and support for people and families living with rare diseases. Learn more about this work (which includes pictures and video of the team climbing Mt. Adams!): https://insights.forgebiologics.com/forge-ahead-launches-with-support-for-be-the-match-and-hope-on-a-summit